Consequently, we overexpressed PAX1 in two cervical cancer cell lines, HeLa and SiHa, and found that it did not significantly inhibit malignant phenotypes, including proliferation, migration, and invasion, in vitro, and tumor growth, in vivo (Fig. 1C–F). Here, PAX1 is linked to cervical cancer.